GT Biopharma, Inc. GTBP
2.96 USD -0.22 (-6.92%)
Regular-session close
2.96 0.00 0.00%
After hours · Nov 20, 4:00 PM ET
2.87 Day range 3.20
2.87 52-week range 23.60
- YTD
- +277.07%
- 1 year
- +319.86%
Held by funds
1 US ETFs and mutual funds hold GTBP · largest positions
- VXF 0.00% of fund $97.41K
Ownership
- Institutions 67.5%
- Insiders 12.1%
- Public and other holders 20.3%
Held by insiders 12.15%
Held by institutions 67.52%
Float held by institutions 76.85%
Institutions 22
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| DekaBank Deutsche Girozentrale | 51.69% | 1,154,867 | 3.25M | Sep 29, 2024 |
| Bank of Montreal /CAN/ | 1.34% | 29,872 | 83.94K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.67% | 15,041 | 42.27K | Sep 29, 2024 |
| Vanguard Group Inc | 0.47% | 10,504 | 29.52K | Sep 29, 2024 |
| Wells Fargo & Company | 0.45% | 10,013 | 28.14K | Sep 29, 2024 |
| Susquehanna International Group, LLP | 0.45% | 10,105 | 28.39K | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.50% | 11,201 | 31.47K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.47% | 10,504 | 29.52K | Sep 29, 2024 |
| Fidelity Total Market Index Fund | 0.10% | 2,196 | 6.17K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.05% | 1,152 | 3.24K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.01% | 255 | 716 | Oct 30, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 3 | 8 | Aug 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BREEN MICHAEL MARTIN | Chief Executive Officer | Stock Award(Grant) | Aug 10, 2023 | 856,218 |
| OHRI MANU | Chief Financial Officer | Stock Award(Grant) | Aug 10, 2023 | 350,000 |
